Cardiovascular Crisis Meets Cutting-Edge Solutions: Insights from the Peripheral Vascular Stents Market Report

Cardiovascular Crisis Meets Cutting-Edge Solutions: Insights from the Peripheral Vascular Stents Market Report

Dublin, September 29, 2023 /PRNewswire/ — “Peripheral Vascular Stents Market Size, Share and Trends Analysis Report, 2023 – 2030” has been added to an offer.

Research and Markets logo

With the increase in peripheral vascular diseases (PVDs), the healthcare sector is relying heavily on innovative solutions such as peripheral vascular stents to effectively manage these conditions. “Peripheral Vascular Stents Market Size, Share, and Trends Analysis Report by Type, Delivery Method, Product, End Use, Region, and Segment Forecast, 2023 – 2030,” delves into the trends and potential of this thriving market.

The report forecasts a strong growth trajectory, supported by technological advances, leading to increased approval of the latest products. It is worth noting that Cordis features the pioneering SMART RADIANZ vascular stent system. Pioneering solutions such as these are revolutionizing radial access, enhancing patient outcomes, and increasing patient satisfaction.

By 2030, the peripheral vascular stent market is expected to reach a global level 2.97 billion US dollars, with a promising CAGR of 7.4% from 2023 onwards. This expected increase is largely due to the increasing prevalence of PVDs. In 2020, cardiovascular disease led to 19.05 million deaths globally, and cerebrovascular disease added another 7.08 million deaths, according to the American Heart Association (AHA).

This escalating health crisis underscores the urgent need for effective interventions. Aside from rising health concerns, the market recovery can also be attributed to continued technological innovations. A notable example is the recent approval of the Cordis SMART RADIANZ vascular stent system by the US Food and Drug Administration in March 2022. Accompanied by the BRITE TIP RADIANZ guide cap and SABERX RADIANZ PTA catheter, this system embodies the continued pursuit of excellence in cardiovascular technology.

Key market highlights from 2022 include:

The drug-eluting stents (DES) segment held the lion’s share at 60.52%. Their ability to effectively reduce restenosis and major adverse cardiac events gives them an advantage over bare metal stents (BMS).

  • Balloon-expanding stents have dominated with a 53.92% market share, providing precise and controlled dilatation of blood vessels, with a preference for less invasive procedures.

  • The iliac artery stent segment represents the largest share at 33.46%, reflecting the prevalence of iliac artery occlusive disease, which affects approximately 8 million individuals in the United States alone.

  • In healthcare infrastructure, hospitals and cardiac centers accounted for 74.54% of the market, demonstrating their pivotal role in the diagnosis and treatment of cardiovascular diseases.

  • geography, north america Leading with a market share of 43.79%, demonstrating advanced healthcare infrastructure and medical expertise.

To provide a thorough understanding of the market, the report has been divided into various chapters, covering topics from methodologies, executive summaries, and market variables to company profiles of industry giants such as Medtronic, Terumo Europe NV, Boston Scientific Inc., Stryker, Biotronik, and more.

For more information about this report visit

About is the world’s leading source of international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, hottest companies, new products and the latest trends.

Media Contact:

Research and markets
Laura Woodmentor manager
Click on

For EST hours, call +1-917-300-0470
To call the US toll free number/CAN +1-800-526-8630
For GMT business hours, call +353-1-416-8900

US fax: 646-607-1907
Fax (outside the US): +353-1-481-1716




View original content:

Source of research and markets

#Cardiovascular #Crisis #Meets #CuttingEdge #Solutions #Insights #Peripheral #Vascular #Stents #Market #Report